Is There A Cure For Hantavirus Infection? 'Breathed In' Virus Kills 38% Of Patients, Scientists Race For Vaccine
A recent Andes hantavirus outbreak on a South American cruise ship killed three and sickened others in May, raising alarms about the 38% fatality rate and the need for a cure or vaccine. The virus spreads primarily through rodent droppings but has shown rare human-to-human transmission, complicating containment efforts and renewing urgency for medical solutions.
A deadly hantavirus outbreak linked to a cruise ship in South America left three people dead and others seriously ill in early May, according to public health officials. The incident involved the Andes strain, which has previously demonstrated limited person-to-person transmission, prompting aggressive responses from health agencies. Hantavirus typically spreads through rodent urine or droppings in enclosed spaces, with a 38% fatality rate, according to Dr. Charles Chiu, an infectious disease specialist at the University of California, San Francisco. Symptoms begin with fever, fatigue, and muscle aches, followed by severe pneumonia as the disease progresses. Early medical intervention improves survival chances, but delayed care worsens outcomes. The cruise ship outbreak has raised concerns about potential human-to-human transmission, as passengers shared cabins and communal spaces. Investigators are analyzing timelines and seating charts to determine whether infections originated from environmental exposure or spread between people. Researchers emphasize the need for a cure or vaccine, as promising candidates remain stalled due to lack of funding. The Andes strain’s rare transmission capabilities have intensified urgency, with governments now facing pressure to prioritize hantavirus research before the next outbreak worsens.
This content was automatically generated and/or translated by AI. It may contain inaccuracies. Please refer to the original sources for verification.